The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,401–1,500 of 1,810
Ruptured Aortic Dissection in an Unrecognized, Late-Term Intrauterine Pregnancy
Jackson, N. R. (2023) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000884
Homeobox A1 Expression in Diabetic Pregnancy: Immunohistochemical and Computational Perspectives
Akdeniz, A. S., Acar, G. E. A., Türe, Z., Aşır, A., AKDENİZ, Ö., Aktaş, A., Aşir, F., Korak, T., & Ağaçayak, E. (2025) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1639075 · Cited by 1
“The pathophysiology of GDM is multifactorial, encompassing β - cell dysfunction, chronic insulin resistance, oxidative stress, and neurohormonal imbalances(2, 3) .”
Gutman, J., & Parrilla, A. (2022) · Precision Nutrition · doi:10.1097/pn9.0000000000000023 · Cited by 3
Joko, S., Hashimoto, T., Yamashita, M., Tsuriya, D., Maekawa, M., & Iwaizumi, M. (2025) · Diabetology International · doi:10.1007/s13340-025-00797-y
“Although the pathogenesis of GDM is unclear, it is believed to be related to dysfunction of pancreatic beta cells, insulin resistance, and release of hormones from the placenta [10].”
Andonotopo, W., Bachnas, M. A., Prabowo, W., Yuliantara, E. E., Pramono, M. B. A., Dewantiningrum, J., Lukas, E., Sanjaya, I. N. H., Wiradnyana, A. A. G. P., Kusuma, A. A. N. J., et al. (2026) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_6_26
Chen, R., Zhang, Y., Meng, X., Ren, X., Lv, T., Sun, Y., & Chen, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1766134
“From a pathophysiological perspective, GDM arises when pregnancy-induced insulin resistance is not adequately compensated by b -cell adaptation, resulting in relative insulin de fi ciency and hyperglycaemia (9).”
Characteristics of pregnant women living with HIV/AIDS and Gestational Diabetes MellitusPreprint
Tsheole, D. O., Bam, N. E., & Mathope, K. (2025) · Research Square · doi:10.21203/rs.3.rs-8077948/v1
Bhanupriya (2025) · Springer eBooks · doi:10.1007/978-981-96-4876-4_6 · Cited by 1
Sex differences in hypertension
Slater, K., Chapman, N., & Colafella, K. M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22266-5.00013-6
Deulkar, S., & Tarnekar, A. M. (2026) · National Journal of Clinical Anatomy · doi:10.4103/njca.njca_221_25
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
Lin, J., Wu, F., Wang, B., Zhu, Q., & Lin, J. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01297-5
“The mechanisms underlying the reduced risk of gestational diabetes with letrozole co-treatment during IVF are currently unknown, but it may be directly or indirectly associated with repaired β-cell function and/ or insulin sensitivity [37].”
BackgroundJafarpour, S., Pasdar, A., Akhlaghi, F., & Hamzehloei, T. (2026) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-026-00886-w
“It is characterized by glucose intolerance with onset or first recognition during pregnancy and poses health risks including perinatal complications and maternal type 2 diabetes (T2DM) [2, 3, 22, 28].”
Anagnostis, P. G., & Goulis, D. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_1
Shukla, R., Kannan, A., Porter, K. W., Summers, C. S., Bhurke, A., Bagchi, M. K., & Bagchi, I. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730181
“…spontaneous maternal hyperglycemia restricted to pregnancy, represents one of the most clinically relevant genetic mouse models of GDM described to date, and it offers a tractable system for dissecting how endometrial metabolic dysfunction can give rise to maternal metabolic disease (41, 42).”
InfluentialCholesterol and early development
Ellinger, I., & Chatuphonprasert, W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00032-8 · Cited by 2
Akinola, I. M., Flynn, K. E., Yee, L. M., Saffian, E., Peterson, Z., & Palatnik, A. (2026) · Pregnancy · doi:10.1002/pmf2.70232 · Cited by 2
“Gestational diabetes mellitus (GDM) affects up to 14% of pregnancies worldwide, accounting for approximately 18 million births each year [1, 2].”
Energy, Nutrition and Metabolism
del Balzo, V., & Asprino, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_22
Serum Cathepsin D Levels in Pregnant Women with Gestational Diabetes Mellitus: A Case-Control Study
Gonca, U. Ç., Hergüner, M., Budak, D., & Kale, İ. (2026) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2942-5811
“The high prevalence of GDM is clinically important not only because of its association with short-term obstetric complications Serum Cathepsin D Levels in Pregnant impaired insulin secretion, or a combination of these factors contribute to the development of GDM [4].”
miR-181a-5p: a key regulator of placental function in health and disease
Lopes‐Aguiar, L., Scandiuzzi, R., Michelazzo, G. F., Geraldo, M. V., Gomes‐Marcondes, M. C. C., Surita, F. G. D. C., Costa, M. L., Than, N. G., & Viana, L. R. (2026) · RNA Biology · doi:10.1080/15476286.2026.2705668
“GDM dysregulates the placental transport of glucose, amino acids, and lipids [74].”
Coltro, D. B., Mateus, J. D. O., Ferreira, I. D. O., Goettert, M. I., Costella, A. P., da Silva, G. L., Torres, I. L. D. S., da Silva, A. A., & Laste, G. (2026) · Journal of Pregnancy · doi:10.1155/jp/4762066 · Cited by 1
“At the maternal–fetal interface, melatonin contributes to oxidative balance and mitochondrial regulation [37].”
伍, 婷. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133581
Saleem, B. N., Abdulridha, M. K., Showman, H. A., & Sabbar, M. (2025) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v25i1.1127
Borissovа, A.-M., Trifonova, B., Dakovska, L. N., Michaylova, E., & Vukov, M. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210602.13
“In general, pregnancy is a condition in which there is high metabolic activity and maintenance of glucose homeostasis is of paramount importance [14].”
BackgroundVelayo, C. L., Suplido, S. A., Sy, A. D. R., Tantengco, O. A. G., Caragay, R. N., & Zuniga, M. (2024) · SciEnggJ · doi:10.54645/202417supulj-62
Zhang, J., Qin, Y., Chen, N., & Wang, J. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s601076
Punnose, J., Malhotra, R. K., Sukhija, K., Mathew, A., Chopra, A., Sharma, A., & Choudhary, N. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100195
“But the pathogenesis, glycemic targets and the natural history of glucose intolerance in pregnancy differ significantly from diabetes mellitus in general population [40].”
BackgroundSujan, M. A. J., Skarstad, H. M. S., Rosvold, G., Fougner, S. L., Nyrnes, S. A., Iversen, A., Follestad, T., Salvesen, K. Å., & Moholdt, T. T. (2023) · medRxiv · doi:10.1101/2023.07.18.23292734
“(1) GDM typically occurs because of pancreatic β-cell dysfunction with preexisting insulin resistance and increases the risk for type 2 diabetes and cardiovascular disease in the mother.(2, 3) Maternal obesity and hyperglycaemia affect the offspring through the egg cell quality, intrauterine environment, and foetal or…”
BackgroundEndocrine and Metabolic Dysfunction and Oro‐Facial Diseases
Chirravur, P., & Chirravur, P. (2024) · Wiley eBooks · doi:10.1002/9781119989233.ch9 · Cited by 2
Advances in Metabonomics of Pregnancy Complications
屈, 奕. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.134886
Histopathological changes in the placentas of pregnant women with Gestational Diabetes Mellitus
Oğlak, S. C., Obut, M., Aşir, F., Yılmaz, E. Z., Bolluk, G., Ağaçayak, E., & Akkuş, M. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i4.6499 · Cited by 2
“Uncontrolled hyperğlycemia durinğ preğnancy causes recurrent interference in both maternal health as well as fetal well-beinğ 5,6,7 .”
BackgroundChowdhury, P., Tofail, T., Akter, N., Islam, H., Bokshi, A., Sultana, M., Podder, S., Malo, M. S., & Hasanat, M. (2026) · medRxiv · doi:10.64898/2026.05.14.26353231
Metformin in the management of gestational diabetes
Rotar, I. C., Stănică, B., Petca, A. T., & Mureșan, D. (2022) · Obstetrica şi Ginecologia · doi:10.26416/obsgin.70.2.2022.6682
Guo, Y., Jiao, J., & Zheng, X. (2026) · Diabetic Medicine · doi:10.1111/dme.70451
Ağaoğlu, R. T., Öztürk, Ö., Şeyhanlı, Z., Karabay, G., Ergani, S. Y., Ulusoy, C. O., Tezcan, A. Y., Azimli, G., Yılmaz, Z. V., & Yücel, K. Y. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08434-x
“Although the etiopathogenesis is not clearly understood, genetic factors, oxidative stress and inflammatory processes as well as anti-insulin hormones such as human placental lacto-gen and progesterone are thought to be responsible [3, 4].”
Liu, L. J., & Chu, Q. (2026) · Journal of Engineering and Science in Medical Diagnostics and Therapy · doi:10.1115/1.4070794
Young, C. D., Garratt, M., Athukorala, T., Perry, T., Ponnampalam, A. P., Crengle, S. M., Peng, M., & Reynolds, A. N. (2026) · BMC Medicine · doi:10.1186/s12916-026-04748-5
“However, in situations of high protein intake (i.e., excess amino acids, causing a state of nutrient overload), the additive effects of amino acids and placental hormones may more strongly impair insulin resistance and contribute to the pathological hyperglycemic state of GDM [57, 58].”
Al-Sharqi, S. A. H., Chaloob, A. K., & Al-Saleem, I. A. A. A. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i1.2428
Aguilar-Rodríguez, E., Martínez‐Carrillo, B. E., Valdés‐Ramos, R., Albor, A. A. R., & Rosales-Gómez, C. (2023) · Revista Ciencia e Innovación Agroalimentaria de la Universidad de Guanajuato · doi:10.15174/cia.v4i2.9
Respiratory Disorders in Children Born to Mothers with Diabetes Mellitus
Прилуцкая, В. А., & Шевцова, А. Ю. (2021) · Репродуктивное здоровье. Восточная Европа · doi:10.34883/pi.2021.11.2.009
Boronat‐Belda, T., Ferrero, H., Soriano, S., Ribes-García, E., Gustems, R. B., Martínez-Bañón, D., Serrano-Selva, M., Martínez‐Pinna, J., Nadal, Á., Quesada, I., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102274 · Cited by 1
“These findings indicate that HFD-P mice developed glucose intolerance, aggravated insulin resistance, altered cytokine levels and decreased pancreatic β -cell function, consistent with our findings in GDM patients and what is described in the literature [37 — 39].”
Guo, S.-H., Xu, J., Gong, Y.-Q., Hu, W., Li, C., & Lü, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574238
Hill, A. (2026) · Wiley eBooks · doi:10.1002/9781394206148.mdp0074
Paul, B., Guillou, S. L., Gourdel, M., Cloteau, C., Laubier, J., Moumen, K. E., David-Sochard, A., Gandon, A., Kaeffer, B., Charlier, M., et al. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110421
Determinants of Poor Glycemic Control among Malaysian Women with Gestational Diabetes Mellitus
Khalim, M. A. A., Rohana, A. J., Sukeri, S., Ahmad, M. H., & Awang, H. (2026) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_199_24
“The multivariable analysis showed that only two variables were significantly associated with poor glycemic control: dietetic counseling and diet self‑efficacy [Table 3].”
InfluentialRezultatele naşterii la vârste materne foarte avansate – experienţa unui centru de nivel 2
Muntean, M., Săsăran, V., Luca, S.-T., et al. (2023) · Obstetrica şi Ginecologia · doi:10.26416/obsgin.71.2.2023.8873
Wang, W., Lu, S., Fu, Y., Yao, Y., & Hu, W. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08677-2
“…(ATMs), which secrete proinflammatory cytokines such as TNF-α, IL-6, and IL-1β that can inhibit insulin signaling and insulin secretion from β-cells, and the key role of low-grade inflammation in the pathogenesis of insulin resistance has become increasingly prominent in recent years [6].”
Study of DNA Damage in Diabetic Mothers and Their Newborn
El-Ella, S. S. A., Ismaeil, M. A. S. A., & Barseem, N. F. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.150437
“X2=21.07 0.0001* Table (2): Comparison between mother who had or hadn't DNA damage regarding lab investigation and random blood sugar Cases Mother DNA damage U p-value No N=39 Yes N=21 Hb -”
BackgroundInfluentialThalapalliyil, K., Bobby, Z., Dorairajan, G., & Toi, P. C. (2026) · Placenta · doi:10.1016/j.placenta.2026.06.017 · Cited by 1
GESTATIONAL DIABETES MELLITUS: UNDERSTANDING THE MECHANISMS ANDMANAGING THE CHALLENGE
Bardhan, S., Saha, S., DAS, A., Banerjee, N., & Mukherjee, S. (2022) · Science and Culture · doi:10.36094/sc.v88.2022.gestational_diabetes_mellitus.bardhan.346
Shu-min, P., Chen, N.-K., Li, X., Xie, X.-Z., Cao, X., & Wang, Z. (2025) · Placenta · doi:10.1016/j.placenta.2025.06.020
Aşir, F., Özkorkmaz, E. G., Dönmezdil, N., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16152404
“Because placental tissues in GDM are exposed to chronic hyperglycemia [15], oxidative stress, and inflammatory activation [16,17], alterations in ERM protein expression may occur as part of trophoblastic adaptation and cytoskeletal remodeling.”
Plaza, B. L., Larrad-Sáinz, A., Valerio, J., Martín-O’Connor, R., del Valle, L., Ramos-Levi, A. M., Barabash, A., Marcuello, C., Jiménez, I., Rubio, M. Á., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1689658 · Cited by 2
“Risk factors for GDM include overweight or obesity, advanced maternal age, excessive gestational weight gain, ethnicity, family history of insulin resistance or diabetes, among others (5).”
Mixed meal tolerance test as a screening method for gestational diabetes: a narrative review
Pragosa, C., Lages, M., Pereira, C., & Guarino, M. P. (2020) · Acta Portuguesa de Nutrição · doi:10.21011/apn.2020.2309
“INTRODUCTION Gestational Diabetes Mellitus (GDM) is defined as the development of chronic hyperglycemia in pregnant women without previously diagnosed diabetes, and it is reported to be one of the most frequent medical complications during pregnancy (1).”
BackgroundJia, Y., Jiang, H., Yu, Y., Fu, Y., Li, Y., & Wang, H. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70289
“That is inconsistent with the physiological mechanism of gestation (Plows et al. 2018; Johns et al. 2018; McIntyre et al. 2019).”
InfluentialYuan, H., Wang, Y., Ren, Q., Ji, X., Yang, J., Wang, Y., Liu, Y., Yuanhuan, W., Sun, R., Yang, H., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1735875
Research advances on the impact of gestational diabetes mellitus on offspring neurodevelopment
Liu, J., Gao, Y., Yi, Y., Wang, T., Chen, Y., & Ma, J. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02175-3
“Such early exposure to hyper-glycemia has been shown to exert deleterious effects on early fetal neurodevelopment [69].”
Bouati, S., Ameen, S., Marzouka, N., Alhantoobi, F., Masuadi, E., Mohammed, G., Mousa, N. A., Mahmoud, S., Seoud, M. A.-F., Mirghani, H. M., et al. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/7913374
“However, when this compensatory mechanism fails — due to β -cell dysfunction or excessive insulin resistance — GDM develops [12 – 15].”
Diet as a Risk Factor for the Development of Gestational Diabetes Mellitus: A Narrative Review
das Chagas, L. A., de Sousa, R. M. L., Mattar, R., Elito, J., & Júnior, E. A. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009119
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_13
Importance of Blood Glucose Monitoring in Pregnant Females
Ghafoor, M., Qayyum, A., Ghazi, A., Khalid, S., Aftab, M., & Shahid, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs20221611256
Bernardes-Oliveira, E., Freitas, D. L. D., Cobucci, R. N., Cornetta, M. D. C. D. M., Camargo, J. D. D. A. S., Lima, K. M. G., & Crispim, J. C. D. O. (2021) · Research Square · doi:10.21203/rs.3.rs-152745/v1
Julphakee, K., Patanabapa, C., Sahassananda, T., Pantungthong, W., Jatavan, P., & Tongsong, T. (2025) · Journal of Pregnancy · doi:10.1155/jp/2527672
“Gestational diabetes mellitus (GDM) is a common metabolic disorder during pregnancy [1], associated with various complications for fetuses and newborns [2], including fetal macrosomia and neonatal hypoglycemia.”
Introduction to Lifestyle Diseases and Role of Herbal Medicines
Dhara, A. K., & Nayak, A. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-7703-1_1
Research Progress of Abnormal Lipid Metabolism in Gestational Diabetes Mellitus
刘, 坤. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112500
Co-morbid Gestational Diabetes and PCOS: Risks and Management
Dheepthi, M., Naveena, B., Jeevika, V. M., & Sowmya, C. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v69i01.014
Muñoz-Nava, M. A., Araujo, M. E. F., Pérez-Luque, E. L., Cardona‐Alvarado, M. I., Ramı́rez-Chávez, E., & Molina‐Torres, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4578221/v1
Gestational diabetes mellitus: Bridging research gaps through a translational framework
Dey, B. K., Basak, M., Maity, S., Roy, S., Kar, A., Chowdhury, S., Roy, S. B., Roy, M., Sahana, P., & Bhattacharjee, R. (2026) · Annals of Medical Science and Research · doi:10.4103/amsr.amsr_30_26
Dietary Fiber Intake and Chronic Diseases Outcome During Pregnancy
Guo, C., Luo, X., Xiao, M., & Zhao, Y. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v2i.553
Le, D. C., Nguyen, T., Lý, N. T., Trần, T. N., Luong, X. H., Do, T. T. H., Tran, X. T., Ngo, V. M., Bui, T. L. Q., Nguyen, T. V., et al. (2026) · JMIR Public Health and Surveillance · doi:10.2196/79688 · Cited by 1
“This finding is consistent with previous studies [3, 12,15,16] and supports the use of lower BMI cutoffs for early risk identification.”
InfluentialThe role of vitamin D in the management and rehabilitation of gestational diabetes mellitus
Zhang, T., Zhou, Q., Shen, L., & Gao, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1817924
Sági, V. (2023) · Lege Artis Medicinae · doi:10.33616/lam.33.0027
Xia, D., Zhang, Y., Liu, W., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202602249rr
“Placental trophoblast cells regulate maternal blood glucose stability by secreting various steroid hormones and cytokines, and placental dysfunction caused by trophoblast cell damage is an important pathogenesis of GDM [3].”
А.Ж., К., Р.Н., И., Жунусова, М. К., Mussabekova, Z., Akhmetova, S. S., Абылгазинова, А. Ж., Мукажанова, А. К., & Yeshova, D. A. (2026) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2026.28.3.031
Zhang, J., Xiao, Y., Wang, Y., Cui, L., Ji, X., Zhang, F., & Wang, Z. (2026) · International Journal of Biometeorology · doi:10.1007/s00484-026-03124-5
“Elevated temperature is associated with beta-cell dysfunction (Retnakaran et al. 2018) and extreme temperatures cause inflammation throughout the body (Deng et al. 2020), both of which are closely related to the pathogenesis of GDM (Plows et al. 2018).”
RELAÇÃO ENTRE STATUS DE FERRO E O SONO EM CRIANÇAS COM TRANSTORNO DO ESPECTRO AUTISTA
dos Santos, L. C., dos Santos, K. E., Costa, D. D. D. M., Alves, S. P. L. B., Brandão, A. D. C. A. S., Hashimoto, J. M., Paiva, A. D. A., & Freitas, B. D. J. E. S. D. A. (2023) · doi:10.56161/sci.ed.20230900c7
Yi, K., Wang, A., & Shan, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1947796
Qian, X., Mei, H., Cao, D., Rao, J., Tang, F., Xiang, Y., & Li, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1888560
“…re fl ect partial pathway convergence: both long cycle and GDM can independently elevate PTB risk, partly through shared insulin-resistance pathways (40); women with GDM have already partially activated this shared pathway, attenuating the additional absolute risk increment attributable to cycle…”
Schernthaner, G.-H., Rami-Merhar, B. M., & Zierfuss, B. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.029
Yasmin, S., Begum, N., Das, T. R., Mahmood, S., & Parvin, M. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20250168
Abu-Awwad, S.-A., Abu-Awwad, A., Farcaş, S. S., Popa, C. A., Tutac, P., Zaharia, I. M., Goina, C. A., Mihailescu, A., & Andreescu, N. I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165792
“Low-grade chronic inflammation is widely recognized as a central factor in the pathophysiology of cardiovascular [1], autoimmune [2], and metabolic diseases [3,4], as well as in obstetrical complications such as preeclampsia and preterm birth [5,6].”
Han, H.-J., Lee, H. J., Kim, T. H., Kwak, M., Kim, J. W., Yang, S. J., Kim, J. Y., Choi, Y. J., Kim, N., Jang, J. H., et al. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e226
“11 Despite advances in understanding GDM, the underlying mechanisms and differential responses to treatment between these two clinical subtypes remain poorly understood.”
Su, J., Luo, J., Huang, X., Huang, Y., & Wang, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1836589
“…resistance increases hepatic gluconeogenesis and impairs glucose uptake in peripheral tissues, leading to elevated basal and postprandial glucose levels (15); Second, insuf-fi cient compensatory b -cell function fails to meet the increased insulin demand required to counteract hyperglycemia (16).”
Insomnia and sleepiness during pregnancy: Associations with gestational diabetes mellitus
Forsbom, O., Perasto, L., Aukia, L., Paavonen, E. J., Mattila, I., Reinilä, S., Karlsson, H., Karlsson, L., & Polo‐Kantola, P. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70013
“12 However, the risk factors for GDM are likely multifactorial, 13 and therefore, additional investigation is required.”
Nigam, A. (2026) · Indian Journal of Medical Specialities · doi:10.4103/injms.injms_322_26
Peled, T., Ben-Ami, T., Helman, S., Lando, M. B., Grisaru‐Granovsky, S., & Rottenstreich, M. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70998
Shahid, M. M., Begum, K., Rahman, K., Fatema, K., & Johora, F. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70268
Pharmacotherapeutic strategies in high-risk pregnancy: Balancing maternal and foetal safety
Saroha, G., Das, R., & Mehta, D. K. (2026) · Scripta Medica · doi:10.5937/scriptamed57-58977
de Souza, A. T. B., Lucas, C. R., de Carvalho, K. T. C., Neta, A. P. R., Bernardes-Oliveira, E., Camargo, J. D. D. A. S., Luchessi, A. D., Cobucci, R. N., & Crispim, J. C. D. O. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22030327
Exercise Benefits for Mother and Offspring: Molecular Mechanisms and Advances
Wu, B., Zhang, Y., & Shi, L. (2025) · Epigenetics and human health · doi:10.1007/978-3-032-08045-5_3 · Cited by 1
Xu, M., Linlin, T., & Yaping, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4117097/v1
Ard, N., Baghsheikhi, H., Shahin, S., Albergamo, V., Cowell, W., Kahn, L. G., Kannan, K., Long, S. E., Ghassabian, A., Mehta‐Lee, S. S., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag018
“In pregnancy, a state characterized by naturally high estrogen levels and a physiological demand for increased insulin secretion [69], this low-dose BPA-induced insulin potentiation could, in theory, transiently enhance β -cell function, and create a paradoxical protective signal against GDM.”
Sabry, A. F., Evers, P. D., & Madriago, E. J. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-03882-w
“Geometric changes or cardiac dysfunction in fetuses of diabetic mothers were more likely related to intrinsic myocardial factors rather than volume or pressure overload.”
Zazula, M. F., Carvalhal, S. R. S., Maciel, D. T., Moritz, D., Beirauti, H. Y. I., Amorim, L., Rocha, M. T., Maciel, M., Sales, O., Dobgenski, P., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136049
“The DOHaD paradigm emphasises that events occurring from the prenatal period to early childhood may permanently modulate physiological systems involved in energy metabolism [296,301,302].”
Martínez‐Carrillo, B. E., Aguilar-Rodríguez, E., Valdés‐Ramos, R., Reséndiz‐Albor, A. A., Rosales-Gómez, C., Luna, R. A. J., & López, A. L. G. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003195 · Cited by 1
Wei, X., Jiang, J., Feng, W., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-8114097/v1
Oguzhanoglu, M. K., & Karacabey, S. (2026) · Anatolian Current Medical Journal · doi:10.38053/acmj.1957626
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.